<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1683-9803</journal-id>
<journal-title><![CDATA[Pediatría (Asunción)]]></journal-title>
<abbrev-journal-title><![CDATA[Pediatr. (Asunción)]]></abbrev-journal-title>
<issn>1683-9803</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1683-98032018000300223</article-id>
<article-id pub-id-type="doi">10.31698/ped.45032018006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Toxoplasmosis ocular: frecuencia y características clínicas en un consultorio de oftalmología pediátrica]]></article-title>
<article-title xml:lang="en"><![CDATA[Ocular Toxoplasmosis: frequency and clinical characteristics in a pediatric ophthalmology clinic]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cardozo]]></surname>
<given-names><![CDATA[Olivia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mesquita]]></surname>
<given-names><![CDATA[Mirta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Godoy]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General Pediátrico &#8220;Niños de Acosta Ñu&#8221;  ]]></institution>
<addr-line><![CDATA[San Lorenzo ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>45</volume>
<numero>3</numero>
<fpage>223</fpage>
<lpage>228</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S1683-98032018000300223&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S1683-98032018000300223&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S1683-98032018000300223&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La toxoplasmosis afecta frecuentemente la cámara posterior del ojo y puede producir pérdida de la visión. Objetivo: Describir la frecuencia y características clínicas de la Toxoplasmosis ocular en un consultorio de oftalmología pediátrica.  Materiales y Métodos:  Estudio observacional, descriptivo retrospectivo Se analizaron las historias clínicas de pacientes de 0 a 18 años de edad, con toxoplasmosis ocular, atendidos en el consultorio de oftalmología pediátrica, desde enero 2011 a mayo de 2014. Variables: edad, sexo, forma de toxoplasmosis, tipo de lesión ocular, localización de la lesión, compromiso unilateral o bilateral, y complicaciones oculares. Los datos se analizaron con SPSSv21 utilizando estadísticas descriptivas e inferenciales. No fue necesario el consentimiento informado porque se trata de un estudio retrospectivo.  Resultados:  Ingresaron 72 pacientes. La mediana de edad 48 meses, fueron neonatos el 6,9%. El 52,8% eran sexo femenino. El 80,5% presentaron toxoplasmosis adquirida y el 19, 4% congénita. Todos los pacientes tenían coriorretinitis. Y en el 7% se acompañaron de uveítis. La afectación fue bilateral en 52.8%. Las lesiones eran inactivas en 87,5 con localización central. Presentaron complicaciones en el 58,3% de los pacientes: estrabismo en 76% y en 24 % desprendimiento de retina.  Conclusión:  La frecuencia de TO fue del 0,8%. La mayoría de los pacientes tenían más de 2 años de edad y el 19% tenía toxoplasmosis congénita. Todos tuvieron corioretinitis, con compromiso bilateral y localización central más frecuentemente. Hubo predominio de lesiones inactivas tanto en la toxoplasmosis congénita como en la adquirida. Las complicaciones fueron estrabismo y desprendimiento de retina.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Toxoplasmosis frequently affects the posterior chamber of the eye and can cause vision loss. Objective: To describe the frequency and clinical characteristics of ocular toxoplasmosis in a pediatric ophthalmology clinic.  Materials and Methods:  this was an observational, descriptive and retrospective study. We reviewed the clinical histories of patients from 0 to 18 years of age, with ocular toxoplasmosis, treated in the pediatric ophthalmology clinic, from January 2011 to May 2014. Variables were age, sex, form of toxoplasmosis, ocular lesion type, lesion location, unilateral or bilateral involvement, and ocular complications. The data was analyzed with SPSSv21 using descriptive and inferential statistics. Informed consent was not necessary because it was a retrospective study.  Results:  72 patients were included. The median age was 48 months; 6.9% were neonates, 52.8% were female. 80.5% had acquired toxoplasmosis and 19.4% congenital. All the patients had chorioretinitis and 7% also had uveitis. Bilateral affectation was present in 52.8%. The lesions were inactive at 87.5% with central location. Complications were present in 58.3% of patients: strabismus in 76% and 24% had retinal detachment.  Conclusion:  The frequency of OT was 0.8%. The majority of the patients were over 2 years of age and 19% had congenital toxoplasmosis. All had chorioretinitis, with bilateral involvement and central location present more frequently. There was a predominance of inactive lesions in both congenital and acquired toxoplasmosis. The most common complications were strabismus and retinal detachment.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Toxoplamosis ocular]]></kwd>
<kwd lng="es"><![CDATA[niños]]></kwd>
<kwd lng="es"><![CDATA[coriorretinitis]]></kwd>
<kwd lng="es"><![CDATA[complicaciones]]></kwd>
<kwd lng="es"><![CDATA[uveitis]]></kwd>
<kwd lng="en"><![CDATA[Ocular toxoplasmosis]]></kwd>
<kwd lng="en"><![CDATA[children]]></kwd>
<kwd lng="en"><![CDATA[chorioretinitis]]></kwd>
<kwd lng="en"><![CDATA[complications]]></kwd>
<kwd lng="en"><![CDATA[uveitis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garza-Leon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arellanes Garcia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular toxoplasmosis Clinical characteristics in pediatric patients]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>2012</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>130-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Congenital toxoplasmosis An overview of the neurological and ocular manifestations]]></article-title>
<source><![CDATA[Parasitol Int]]></source>
<year>2018</year>
<volume>67</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>715-21</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cerqueira Lima]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Saraiva]]></surname>
<given-names><![CDATA[PGC]]></given-names>
</name>
<name>
<surname><![CDATA[Saraiva]]></surname>
<given-names><![CDATA[FP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current Therapy of Acquired Ocular Toxoplasmosis A Review]]></article-title>
<source><![CDATA[J Ocul Pharmacol Ther]]></source>
<year>2015</year>
<volume>31</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>511-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furtado]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Winthrop]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular toxoplasmosis I parasitology, epidemiology and public health]]></article-title>
<source><![CDATA[Clin Experiment Ophthalmol]]></source>
<year>2013</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>82-94</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Commodaro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chiasson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sundar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzo]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
<name>
<surname><![CDATA[Belfort Rubens]]></surname>
<given-names><![CDATA[GME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elevated toxoplasma gondii infection rates for retinas from eyes bank southern Brazil]]></article-title>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>2015</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>691-3</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arantes]]></surname>
<given-names><![CDATA[TEF]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Holland]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Muccioli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular involvement following postnatally acquired toxoplasma gondii infection in southern brazil: A 28-year experience]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2015</year>
<volume>159</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1002-1012.e2</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rudzinski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia y factores de riesgo asociados con toxoplasmosis ocular en la zona centroeste de la provincia de Misiones, Argentina]]></article-title>
<source><![CDATA[Oftalmol Clin Exp]]></source>
<year>2011</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>159-62</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abu]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[Boampong]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Amoabeng]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Ilechie]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Kyei]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Owusu-Ansah]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Ocular Toxoplasmosis in Three Community Surveys in the Central Region of Ghana, West Africa]]></article-title>
<source><![CDATA[Ophthalmic Epidemiol]]></source>
<year>2016</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jong]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Matthew]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[A EZ]]></surname>
</name>
<name>
<surname><![CDATA[B AH]]></surname>
</name>
<name>
<surname><![CDATA[Tajudin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical profile of ocular toxoplasmosis in the Universiti Sains Malaysia Hospital - 7-year review]]></article-title>
<source><![CDATA[Family Medicine &amp; Primary Care Review]]></source>
<year>2018</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jaimes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Host and Toxoplasma gondii genetic and non-genetic factors influencing the development of ocular toxoplasmosis A systematic review]]></article-title>
<source><![CDATA[Infect Genet Evol]]></source>
<year>2016</year>
<volume>44</volume>
<page-range>199-209</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de-la-Torre]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sauer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pfaff]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Bourcier]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Brunet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Speeg-Schatz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe South American Ocular Toxoplasmosis Is Associated with Decreased Ifn-?/Il-17a and Increased Il-6/Il-13 Intraocular Levels]]></article-title>
<source><![CDATA[PLoS Negl Trop Dis]]></source>
<year>2013</year>
<volume>7</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grigg]]></surname>
</name>
<name>
<surname><![CDATA[Michael]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dubey Jitender P NRB Ocular Toxoplasmosis:lessons From Brazil]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2015</year>
<volume>159</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>999-1001</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Melamed]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Eckert]]></surname>
<given-names><![CDATA[GU]]></given-names>
</name>
<name>
<surname><![CDATA[Spadoni]]></surname>
<given-names><![CDATA[VS]]></given-names>
</name>
<name>
<surname><![CDATA[Lago]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Uberti]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular manifestations of congenital toxoplasmosis]]></article-title>
<source><![CDATA[Eye]]></source>
<year>2010</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>528-34</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pleyer]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Schlüter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mänz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular toxoplasmosis Recent aspects of pathophysiology and clinical implications]]></article-title>
<source><![CDATA[Ophthalmic Res]]></source>
<year>2014</year>
<volume>52</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>116-23</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De-La-Torre]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González-López]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Montoya-Gutiérrez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Marín-Arango]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Marín]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life assessment in ocular toxoplasmosis in a Colombian Population]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>2011</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>262-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De-La-Torre]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Stanford]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Curi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jaffe]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez-Marin]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapy for ocular toxoplasmosis]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>2011</year>
<volume>19</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>314-20</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harrell]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carvounis]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current treatment of toxoplasma retinochoroiditis: An evidence-based review]]></article-title>
<source><![CDATA[J Ophthalmol]]></source>
<year>2014</year>
<volume>2014</volume>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pradhan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bhandari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gilbert]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Stanford]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotics versus no treatment for toxoplasma retinochoroiditis]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2016</year>
<volume>2016</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oray]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ozdal]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Cebeci]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kir]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tugal-Tutkun]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fulminant Ocular Toxoplasmosis The Hazards of Corticosteroid Monotherapy]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>2016</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>637-46</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Persons]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Province]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rudzinski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Khoury]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Couto]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ajzenberg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reactivation of Ocular Toxoplasmosis in Tropical Islands as New Hubs for Emerging]]></article-title>
<source><![CDATA[Arboviruses]]></source>
<year>2016</year>
<volume>22</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>912-3</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isenberg]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Golizeh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Belfort]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[da Silva]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Burnier]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Ndao]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peptidyl-prolyl cis-trans isomerase A - A novel biomarker of multi-episodic (recurrent) ocular toxoplasmosis]]></article-title>
<source><![CDATA[Exp Eye Res]]></source>
<year>2018</year>
<volume>177</volume>
<page-range>104-11</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takeda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ishibashi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sonoda]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Uveitis, Caused by HTLV-1, Toxoplasmosis, and Tuberculosis; the Three Leading Causes of Endemic Infectious Uveitis in Japan]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>2017</year>
<volume>25</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>S19-23</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kijlstra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology, pathophysiology, and the future of ocular toxoplasmosis]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>2014</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>138-47</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
